Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2

NCT: NCT07300579 · NOT_YET_RECRUITING

NCT IDNCT07300579
StatusNOT_YET_RECRUITING
Start Date2026-06
Completion2032-06

Brief Summary

VISION-2 is an international, multi-site, prospective observational cohort study of 20,000 patients undergoing noncardiac surgery. Continuous biometric data will be blindly collected for the first 30 postoperative days, in hospital and at home, using Vitaliti™. Following study enrollment and baseline data collection, follow up visits will occur in-hospital, at 30-days, and 1-year post-operatively. VISION-2 has 3 primary objectives, among participants who underwent noncardiac surgery, the investigators will: 1) determine the pattern and frequency of physiological precursors (i.e., biophysical signals) to MINS, BIMS, sepsis, and infection without sepsis; 2) build prediction models from these biophysical signals and their extracted features through supervised machine learning, for the prediction and early detection of those complications; and 3) build a biobank for evaluation of novel biomarkers.

Frequently Asked Questions

What is Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2?

Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2 is a clinical trial registered under NCT07300579. Current status: NOT_YET_RECRUITING.

What is the status of NCT07300579?

The current status of NCT07300579 (Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2) is: NOT_YET_RECRUITING.

When did Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2 start?

Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2 started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.